Le Lézard
Classified in: Science and technology, Business

BidFX Completes Integration with Orchestrade Financial Systems to Offer Clients Full eFX


LONDON, June 21, 2018 /PRNewswire/ -- BidFX, the industry leading EMS designed for the $5 Trillion daily FX market, today announced full integration with Orchestrade's core portfolio management and risk system.

Clients ranging from asset managers to hedge funds can now benefit from this integration which results in seamless communication and connectivity between BidFX's Execution Management System (EMS) and Orchestrade's Portfolio Management Service (PMS). 

"We are very happy to announce our strategic integration with Orchestrade, one of the leading cross-asset portfolio management platforms in the marketplace today. At BidFX we are continually driven by our clients' needs and desire to sit at the forefront of eFX trading and workflow. This partnership enables BidFX clients to quickly deploy a true end-to-end FX solution," said Jean-Philippe Male, BidFX Chief Executive Officer.

"Our mission is to provide the fastest time and value to market in the capital market industry by offering a scalable platform that is pre-configured with major market standard data and services providers such as BidFX," states Gordon Chan, Orchestrade Vice President Marketing.

Orchestrade is the only institutional-grade cross-asset capital market platform launched after the financial crisis. It is designed to dramatically reduce IT dependency during implementation and operation by delivering a native cross-asset end-to-end solution that is connected to the broader capital market ecosystem out of the box.

BidFX and its parent company TradingScreen (TS) actively engages with firms on strong and effective partnerships to help enhance buy-side's trading workflow and provide innovative solutions that empower our clients. 

About BidFx
BidFX is a TradingScreen (TS) company and the leading provider of electronic trading solutions for the global financial marketplace. BidFX clients have access to cutting edge execution management, encompassing a complete suite of negotiation tools and a hub to all major banks Algo suites. BidFX fulfills the ideal as the one truly multi-asset, broker-neutral EMS in the marketplace today. For more information visit: www.bidfx.com.

About Orchestrade Financial Systems
Founded in 2009, Orchestrade Financial Systems delivers the most modern technology for cross asset, front-to-back trading and risk management. Its award-winning capital markets platform has been implemented by leading financial institutions in North America, Europe and Asia. Orchestrade is headquartered in Silicon Valley with offices in Paris, London and New York.

Press Contacts

BidFX

Marissa Arnold
Media Inquiries: [email protected] 
Business Inquiries: [email protected] 
+1-612-309-9564

Orchestrade
[email protected]

SOURCE BidFX


These press releases may also interest you

at 03:07
Global consulting firm J.S. Held, proudly celebrating 50 transformative years, announces the promotion of 93 distinguished experts across multiple practices and geographies. These well-deserved senior expert promotions span the firm's areas of...

at 03:07
Creative Group, a full-service meeting, incentive, and recognition agency, is thrilled to announce the resounding success of its clients' 2023 incentive programs, showcasing a remarkable return on investment and unprecedented participant engagement....

at 03:01
New research from Beko, the home appliance brand, has revealed the most weird and wonderful items that consumers have inherited. 77%...

at 03:00
DWF Labs, a new generation Web3 investor, will be onboarding as Klaytn's latest Governance Council (GC) member, with their GC membership application having passed on-chain voting with 98% in favor. In a bold move to demonstrate their commitment to...

at 03:00
Today McLeod Software announced their enhanced solution for private fleet trucking operations, called LoadMaster Private Fleet. The solution is built on the company's proven LoadMaster Enterprise operations software, already used by dozens of private...

at 03:00
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...



News published on and distributed by: